Peter Marks, the former head of the FDA’s Center for Biologics Evaluation and Research (CBER) and a prominent critic of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., landed a new job at pharma giant Eli Lilly.
Marks will join the company as senior vice president of molecule
Continue reading

Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!